BSE filing, NSE: NEOGEN. Summary written from the filing by ALFA Finder's alert engine.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,171.40
- Market cap
- ₹6,523 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 183.4×Sector 34.1×
- Promoter holding
- 48.31%-4.70% QoQ
- FII holding
- 4.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.
Neogen Chemicals Debt & Borrowing: ₹500 Cr
Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.
- Value
- ₹500.0 Cr
Neogen Chemicals Capacity Expansion: ₹45 Cr Investment
Neogen Chemicals' board approved a capacity addition of 600 MT/PA with a Rs 45.00 Crore investment. Funding will come from internal accruals and debt.
- Value
- ₹45.00 Cr
- Execution
- By end of next financial year
- manufacturing capacity
- 600.0 MTPA
Neogen Chemicals Other Announcement
Neogen reports no deviation in QIP fund utilisation for the quarter ended September 30, 2026. This is a periodic utilisation report, not a new transaction.
Neogen Chemicals Q2 FY27 Results: Net Profit ₹8.2 Cr, Up 141.2% YoY
Neogen Chemicals Ltd reported revenue from operations of ₹296 Cr (+41.8% YoY) and net profit of ₹8.2 Cr (+141.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.2 Cr · +141.2% YoY
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Other results update announcements
All →Medi Assist Healthcare Services Results Update
Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.
Surani Steel Tubes Results Update
Surani Steel Tubes issued an earnings press release for H1 FY27, reporting revenue of Rs.290.86 Crore and PAT of Rs.5.94 Crore. The release states that both figures exceed the company's previous full-year records.
Shree Ganesh Remedies Results Update
Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.
Zen Technologies Results Update
Zen Technologies released its Q2 and H1 FY27 unaudited results, reporting consolidated Q2 revenue of ₹345.13 Crore, up 98.8% year-on-year. Order book stands at ₹1,375.70 Crore.
- Order book
- ₹1,376 Cr
Sai Parenterals Results Update
Sai Parenterals reported Q2FY27 consolidated revenue of Rs. 196 crore and PAT of Rs. 11 crore. Gross margin improved to 47.5%.
SPR Auto Technologies Results Update
SPR Auto's Q2FY27 consolidated Total Income rose 61% YoY, with EBITDA up 29%. Standalone PAT declined 11% YoY in the quarter.